Delicious
Digg
Facebook
LinkedIn
Twitter
Investors and Media
Our mission as a biotechnology company is to research, develop and commercialize a next-generation of small molecule cancer therapeutics. We are combining innovative, proprietary anti-cancer technology with world-class chemistry capabilities to generate drug candidates that target multiple tumor types, act selectively against cancer cells and are well tolerated by patients. Our lead products are in clinical development, and our research pipeline targets multiple molecules with established roles and therapeutic potential in cancer.
We are headquartered and operate research facilities and development programs in Woburn, Massachusetts.
Recent Releases
May 8, 2013
ArQule Reports First Quarter 2013 Financial Results
May 1, 2013
ArQule to Report First Quarter 2013 Financial Results on May 8, 2013
Recent Events
May 8, 2013 at 9:00 AM ET
Q1 2013 ArQule, Inc. Earnings Conference Call
Apr 30, 2013 at 10:40 AM
Needham 12th Annual Healthcare Conference
Corporate Presentation
May 1, 2013
 |
View Presentation 1.7 MB |
| Stock Chart | Stock Quote | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
||||||||||||||
Transfer Agent
American Stock and Transfer
41 Wall Street
New York City, NY 10005
Phone: 212-936-5100